Over the next seven years, the molecular diagnostics market is poised for a magnificent spike in CAGR in terms of revenue. Molecular diagnostics has emerged as...
Molecular diagnostics has become an important pillar of healthcare in the current times. With the advancements in its techniques, molecular diagnostic is benefitting clinical medical settings....
The future of medical diagnostics lies in the genomics and proteomics, thereby reassuring the significance and demand for nucleic acid amplification tests in the clinical sector....
The molecular testing result available much faster than result from culture opens a wide range of opportunities for the segment, such as testing of patients with...
Ongoing advances will continue to shape MDx landscape, not only from a technical perspective but also with interconnected logistical, financial, and regulatory factors that are critical...
It is expected to maintain its dominance in upcoming years owing to its wide adoption in research and clinical settings. Standardized results, improved efficiency, and cost-effectiveness...
As the need for COVID-19 testing collapses to a fraction of its current demand, molecular diagnostics companies will be holding and maintaining facilities that can create...
The Indian MDx market saw an additional ₹7000 crore sales on account of RT-PCR testing. As the world rushes to become vaccinated against the COVID-19, the...
The high demand for molecular diagnostics could seed structural shifts that will have long-term implications for diagnostic-test manufacturers. With high technological and regulatory barriers to entry,...
Granting an EUA was perhaps essential at that point, but it brought to the fore weaknesses inherent in the system. As the coronavirus wildfire raged across...
Testing has been playing a pivotal role in tracking and management of global COVID-19 pandemic. The continuously increasing demand for reliable COVID-19 detection tests has encouraged...
The sudden onset of SARS-CoV-2 and the resulting disease COVID-19 has put the world’s focus on molecular diagnostics in an unexpected way. 2020 was set to...
Molecular diagnostics companies have laid the foundation for nothing short of a revolution in cancer care – it is time for the MedTech sector to develop...
The contribution of molecular testing to modern medicine is not finished yet. Two decades ago, the thinking was that diagnostics would be largely conducted at the...
HBV,HCV, HIV, and TB with a combined contribution of 78 percent dominate the clinical molecular diagnostics segment. This is expected to continue till TB is eradicated...
Copyright © 2023 Medical Buyer